Align Technology, Inc. ALGN
146.78
1.15
0.79%
as of 25 Sep
- Market cap
- $10.4B
- P/E
- 25.5×
Follow ALGN
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Align Technology, Inc. (ALGN) P/E ratio
As of 25 September 2026, Align Technology, Inc. (ALGN) trades at a P/E ratio of 25.5×. Over the past ten years it has ranged from 6.3× (April 2020) to 115× (June 2018); the current reading is higher than 10% of that period. That is below the Medical Instruments & Supplies industry median of 34.2× and above the Healthcare sector median of 22.7×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 27.6× | (25.64%) |
| FY2024 | 37.1× | (19.57%) |
| FY2023 | 46.1× | 0.39% |
| FY2022 | 45.9× | (31.62%) |
| FY2021 | 67.2× | 184.06% |
| FY2020 | 23.7× | (52.78%) |
| FY2019 | 50.1× | 19.60% |
| FY2018 | 41.9× | (46.11%) |
| FY2017 | 77.7× | 90.78% |
| FY2016 | 40.7× | 11.36% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 29.3× | 1.97% |
| Mar 2026 | 28.7× | 4.08% |
| Dec 2025 | 27.6× | 13.68% |
| Sep 2025 | 24.3× | (23.99%) |
| 42 more quarters | Free account |
Against its own ten years
Low 6.3×
High 115×
Ten-year median
40.4×
Current reading's percentile
10
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| AVTR Avantor, Inc. compare | n/m |
| BAX Baxter International Inc. compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| SOLV Solventum Corporation compare | 10.9× |
| COO The Cooper Companies, Inc. compare | 18.9× |
| ATR AptarGroup, Inc. compare | 22.1× |
| ALGN Align Technology, Inc. | 25.5× |
| STVN Stevanato Group S.p.A. compare | 37.7× |
| RGEN Repligen Corporation compare | 253× |
| Medical Instruments & Supplies industry median | 34.2× |
| Healthcare sector median | 22.7× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ALGN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement